VOLTAS LTD
Last Traded Price @ 1355
Support Range @ 1330 / 1317
Resistance Range @ 1368 / 1373
Voltas Ltd. shares are likely to rise in the coming days. The company’s new product launches, product diversification and strong brand image are attracting investors. Increasing margins in the retail and home appliance segments are helping to increase profitability. Operational efficiency and strong market position create a positive environment for the stock in the long term.
AURO PHARMA
Last Traded Price @ 1201
Support Range @ 1188 / 1173
Resistance Range @ 1217 / 1225
Aurobindo Pharma shares are likely to rise in the coming days. The company is continuously getting new ANDA approvals in the US market, due to which its product portfolio has become stronger and profitability is expected to increase. Recently, the company has increased investment in API and biosimilar segments, which can prove to be important for growth in the long term. Also, increasing demand for global healthcare products are giving additional benefit to export-oriented companies.
JSW STEEL
Last Traded Price @ 1129
Support Range @ 1107 / 1097
Resistance Range @ 1143 / 1150
JSW Steel shares are likely to rise in the coming days. Demand for steel in the local and international markets has been strong, which can help increase the company’s revenue. The decline in raw material prices is favorable for profitability. Strong order book and engagement in infrastructure projects give a positive signal for the stock. All these factors can support the share price.
HDFC BANK
Last Traded Price @ 1005
Support Range @ 990 / 974
Resistance Range @ 1014 / 1025
There are several strong factors that are likely to drive HDFC Bank’s share price higher in the coming days. The first is that the bank’s loan portfolio is growing steadily, especially in the retail and home loan segments, with strong demand. The bank’s asset quality has remained stable and the NPA ratio is declining, which is a sign of confidence for investors.
ZYDUS LIFE
Last Traded Price @ 931
Support Range @ 909 / 898
Resistance Range @ 947 / 960
The potential for Zydus Lifesciences shares to rise in the coming days is mixed. Demand for the company’s medicines and healthcare products is strong, but competition and regulatory challenges in the global market can sometimes impact profitability. Focus on R&D and a portfolio of new products will be positive for the stock in the long term. Also, exports and international distribution network support the stock.
Ravi Bhatt
SEBI Registered Research Analyst
SEBI Registration Number: – INH000012591
Disclaimer – https://www.capsavaj.com/policies
The securities quoted are for illustration only and are not recommendatory. Investment in securities market are subject to market risks. Read and agree Disclaimer and related all the documents carefully before investing, mentioned on www.nikhilbhatt.in
